These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2667892)

  • 21. Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences.
    Newbould E; Pinto A; Evans S; Ford S; O'Driscoll M; Ashmore C; Daly A; MacDonald A
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33672234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A facile HPLC method for optical purity and quantitative measurements of phenylalanine from the hydrolyzed aspartame under different pH and temperature after its derivatization with a fluorescent reagent.
    Hsien TJ; Chen S
    Amino Acids; 2007 Jul; 33(1):123-8. PubMed ID: 17068663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of aspartame--methyl ester of L-aspartyl-L-phenyl- alanine using the amino acid analyzer].
    Timokhina EA; Liublinskaia LA; Boĭtsova SE; Stepanov VM
    Prikl Biokhim Mikrobiol; 1987; 23(3):426-8. PubMed ID: 3615381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sour welcome for aspartame.
    Beardsley T
    Nature; 1983 Sep 15-21; 305(5931):175. PubMed ID: 6888558
    [No Abstract]   [Full Text] [Related]  

  • 25. Ion-pair high-performance liquid chromatographic analysis of aspartame and related products.
    Verzella G; Bagnasco G; Mangia A
    J Chromatogr; 1985 Dec; 349(1):83-9. PubMed ID: 4086646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of aspartame in pregnancy.
    Sturtevant FM
    Int J Fertil; 1985; 30(1):85-7. PubMed ID: 2862125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fluorimetry in pharmaceutical analysis. III. Fluorimetric determination of alpha-L-aspartyl-L-phenylalanine methylester hydrochloride (aspartame)].
    Poctová M; Kakác B
    Cesk Farm; 1982 May; 31(3-4):113-5. PubMed ID: 7094037
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative metabolism of aspartame in experimental animals and humans.
    Ranney RE; Oppermann JA; Muldoon E; McMahon FG
    J Toxicol Environ Health; 1976 Nov; 2(2):441-51. PubMed ID: 827618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical changes following high-dose aspartame with dietary carbohydrates.
    Wurtman RJ
    N Engl J Med; 1983 Aug; 309(7):429-30. PubMed ID: 6877300
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of aspartame in phenylketonuric heteroxygous adults.
    Koch R; Shaw KN; Williamson M; Haber M
    J Toxicol Environ Health; 1976 Nov; 2(2):453-7. PubMed ID: 796477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.
    Hertelendy ZI; Mendenhall CL; Rouster SD; Marshall L; Weesner R
    Am J Gastroenterol; 1993 May; 88(5):737-43. PubMed ID: 8480740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspartame as a dietary trigger of headache.
    Lipton RB; Newman LC; Cohen JS; Solomon S
    Headache; 1989 Feb; 29(2):90-2. PubMed ID: 2708042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aspartame, a sweet alternative].
    Drenth JP; Kleinjans JC
    Ned Tijdschr Geneeskd; 1988 Apr; 132(16):712-5. PubMed ID: 3374651
    [No Abstract]   [Full Text] [Related]  

  • 34. Aspartame: review of safety.
    Butchko HH; Stargel WW; Comer CP; Mayhew DA; Benninger C; Blackburn GL; de Sonneville LM; Geha RS; Hertelendy Z; Koestner A; Leon AS; Liepa GU; McMartin KE; Mendenhall CL; Munro IC; Novotny EJ; Renwick AG; Schiffman SS; Schomer DL; Shaywitz BA; Spiers PA; Tephly TR; Thomas JA; Trefz FK
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 2):S1-93. PubMed ID: 12180494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision on Aspartame due this year.
    Holden C
    Science; 1980 Feb; 207(4433):856-7. PubMed ID: 7355267
    [No Abstract]   [Full Text] [Related]  

  • 36. The debate over neurotransmitter interaction in aspartame usage.
    Choudhary AK; Lee YY
    J Clin Neurosci; 2018 Oct; 56():7-15. PubMed ID: 30318075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aspartame and phenylalanine on meal-time food intake of humans.
    Anderson GH; Leiter LA
    Appetite; 1988; 11 Suppl 1():48-53. PubMed ID: 3056266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspartame and Phe-Containing Degradation Products in Soft Drinks across Europe.
    van Vliet K; Melis ES; de Blaauw P; van Dam E; Maatman RGHJ; Abeln D; van Spronsen FJ; Heiner-Fokkema MR
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32599819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New data on the metabolism and physiologic mechanisms of aspartame action].
    Tutel'ian VA; Gapparov MM; Virovets OA; Kravchenko LV; Vasil'ev AV
    Vopr Pitan; 1989; (1):20-5. PubMed ID: 2718412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects.
    Filer LJ; Stegink LD
    Diabetes Care; 1989 Jan; 12(1):67-74. PubMed ID: 2653751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.